Extendicare Inc.

TSX:EXE.TO

14.43 (CAD) • At close May 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Revenue 1,466.2021,304.9571,221.5771,166.9871,103.5441,131.951,120.0071,097.3311,060.758943.279816.119783.8092,037.4132,094.0822,069.1032,167.1962,064.3881,763.871,745.4721,971.7681,746.81,671.3441,755.6741,704.5111,807.4061,892.6872,112.868
Cost of Revenue 1,298.2071,137.3351,144.7481,051.379902.3881,038.2851,021.488993.237930.622851.351708.096677.7121,780.0191,824.7911,782.7161,823.0791,770.8981,519.3271,541.1451,673.7751,505.9781,468.2300000
Gross Profit 167.995167.62276.829115.608201.15693.66598.519104.094130.13691.928108.023106.097257.394269.291286.387344.117293.49244.543204.327297.993240.822203.1141,755.6741,704.5111,807.4061,892.6872,112.868
Gross Profit Ratio 0.1150.1280.0630.0990.1820.0830.0880.0950.1230.0970.1320.1350.1260.1290.1380.1590.1420.1390.1170.1510.1380.12211111
Reseach & Development Expenses 000000000000000000000000000
General & Administrative Expenses 1,199.555.8351,036.281959.67248.95941.15139.74638.22539.06337.44833.35736.54474.14180.15472.62472.81800000000000
Selling & Marketing Expenses 00-985.206-889.87900000000000.006000000000000
SG&A 1,199.555.83551.07569.79348.95941.15139.74638.22539.06337.44833.35736.54474.14180.15472.6372.81887.43576.813.74530.64815.64618.21700000
Other Expenses 155.489000174.41400033.33027.098-11.09684.735128.0741.708265.6760.1616.689-27.774056.87363.6571,571.2141,549.1521,683.991,749.6131,859.78
Operating Expenses 1,354.98955.83550.77552.4311,103.54441.15139.74638.22537.20136.09960.45536.544157.458208.228314.7338.488147.595281.692204.32797.53473.103203.1141,571.2141,549.1521,683.991,749.6131,859.78
Operating Income 111.21362.96220.98749.70893.30152.70938.77366.21857.74383.69147.56845.951106.44861.063168.301222.602143.537156.518141.818161.034166.589123.792184.46155.359123.416143.074253.088
Operating Income Ratio 0.0760.0480.0170.0430.0850.0470.0350.060.0540.0890.0580.0590.0520.0290.0810.1030.070.0890.0810.0820.0950.0740.1050.0910.0680.0760.12
Total Other Income Expenses Net -11.352-18.159-25.483-35.723-34.616-30.725-26.454-23.654-18.915-46.141-30.95-29.656-68.253-82.944-71.012-96.84-111.614-47.948-180.673-12.966-48.767-57.018-161.844-215.079-227.18-394.984-78.151
Income Before Tax 99.86144.803-4.49613.98558.68521.98412.31942.56438.82837.5516.61816.29538.195-21.88197.289125.76231.923108.57-38.855148.068117.82266.77422.616-59.72-103.764-251.91174.937
Income Before Tax Ratio 0.0680.034-0.0040.0120.0530.0190.0110.0390.0370.040.020.0210.019-0.010.0470.0580.0150.062-0.0220.0750.0670.040.013-0.035-0.057-0.1330.083
Income Tax Expense 24.65210.8210.0156.48116.2357.1854.23510.8527.41113.845.5496.1310.57213.44244.47945.60323.85935.0438.29649.731-3.71724.53911.202-12.659-36.916-69.219112.149
Net Income 75.20933.98269.55411.50454.18928.6331.7382.13235.452232.078-18.7535.28362.656-30.39651.68777.70813.38870.381-35.72894.195124.29260.67418.934-36.406-59.278-159.70265.332
Net Income Ratio 0.0510.0260.0570.010.0490.0250.0280.0020.0330.246-0.0230.0070.031-0.0150.0250.0360.0060.04-0.020.0480.0710.0360.011-0.021-0.033-0.0840.031
EPS 0.970.4-0.0510.130.60.320.360.020.42.64-0.210.060.74-0.360.51.060.181-0.531.371.820.870.26-0.52-0.81-2.140.85
EPS Diluted 0.860.4-0.0510.130.60.320.320.020.42.41-0.190.060.68-0.360.51.020.181-0.521.351.790.860.26-0.52-0.81-2.140.85
EBITDA 152.51998.63248.90267.457125.07790.50275.368102.37497.39592.65673.71672.784180.306144.411237.275290.23183.411206.59207.232229.331223.616187.449253.449226.906195229.954335.773
EBITDA Ratio 0.1040.0760.040.0580.1130.080.0670.0930.0920.0980.090.0930.0880.0690.1150.1340.0890.1170.1190.1160.1280.1120.1440.1330.1080.1210.159